nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—SLCO2B1—Rifampicin—leprosy	0.128	0.168	CbGbCtD
Ibuprofen—UGT1A1—Rifampicin—leprosy	0.0953	0.125	CbGbCtD
Ibuprofen—ABCC1—Rifampicin—leprosy	0.0783	0.103	CbGbCtD
Ibuprofen—SLCO1A2—Rifampicin—leprosy	0.0699	0.092	CbGbCtD
Ibuprofen—PTGS2—Thalidomide—leprosy	0.0591	0.0778	CbGbCtD
Ibuprofen—PTGS1—Thalidomide—leprosy	0.0499	0.0657	CbGbCtD
Ibuprofen—PTGS2—Dapsone—leprosy	0.0473	0.0622	CbGbCtD
Ibuprofen—PTGS1—Dapsone—leprosy	0.0399	0.0526	CbGbCtD
Ibuprofen—CYP2C8—Rifampicin—leprosy	0.0279	0.0367	CbGbCtD
Ibuprofen—CYP2C19—Thalidomide—leprosy	0.0242	0.0318	CbGbCtD
Ibuprofen—CYP2C19—Rifampicin—leprosy	0.0234	0.0308	CbGbCtD
Ibuprofen—CYP2C8—Dapsone—leprosy	0.023	0.0303	CbGbCtD
Ibuprofen—CYP2C9—Thalidomide—leprosy	0.0201	0.0265	CbGbCtD
Ibuprofen—CYP2C9—Rifampicin—leprosy	0.0195	0.0256	CbGbCtD
Ibuprofen—CYP2C19—Dapsone—leprosy	0.0193	0.0254	CbGbCtD
Ibuprofen—ABCB1—Rifampicin—leprosy	0.0189	0.0249	CbGbCtD
Ibuprofen—CFTR—sweat—leprosy	0.0183	0.261	CbGeAlD
Ibuprofen—CYP2C9—Dapsone—leprosy	0.0161	0.0212	CbGbCtD
Ibuprofen—Renal papillary necrosis—Dapsone—leprosy	0.0149	0.111	CcSEcCtD
Ibuprofen—CFTR—nose—leprosy	0.0126	0.179	CbGeAlD
Ibuprofen—Hypoalbuminaemia—Dapsone—leprosy	0.00642	0.0481	CcSEcCtD
Ibuprofen—THBD—blood vessel—leprosy	0.00396	0.0565	CbGeAlD
Ibuprofen—Creatinine low—Thalidomide—leprosy	0.00374	0.028	CcSEcCtD
Ibuprofen—Blood creatinine decreased—Thalidomide—leprosy	0.00342	0.0257	CcSEcCtD
Ibuprofen—Nephrotic syndrome—Dapsone—leprosy	0.0029	0.0217	CcSEcCtD
Ibuprofen—PPARG—hindlimb—leprosy	0.00281	0.04	CbGeAlD
Ibuprofen—Gastrointestinal perforation—Thalidomide—leprosy	0.00275	0.0206	CcSEcCtD
Ibuprofen—Hypoproteinaemia—Thalidomide—leprosy	0.00244	0.0183	CcSEcCtD
Ibuprofen—PPARG—appendage—leprosy	0.00241	0.0343	CbGeAlD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.00197	0.0537	CbGpPWpGaD
Ibuprofen—BCL2—IL2 signaling events mediated by STAT5—LTA—leprosy	0.0019	0.0518	CbGpPWpGaD
Ibuprofen—THBD—skin of body—leprosy	0.00183	0.0262	CbGeAlD
Ibuprofen—Intestinal perforation—Thalidomide—leprosy	0.00181	0.0136	CcSEcCtD
Ibuprofen—Proteinuria—Dapsone—leprosy	0.00159	0.012	CcSEcCtD
Ibuprofen—Protein urine present—Dapsone—leprosy	0.00157	0.0118	CcSEcCtD
Ibuprofen—Neck stiffness—Thalidomide—leprosy	0.00151	0.0113	CcSEcCtD
Ibuprofen—PLAT—eye—leprosy	0.00149	0.0212	CbGeAlD
Ibuprofen—Sinus bradycardia—Thalidomide—leprosy	0.00146	0.011	CcSEcCtD
Ibuprofen—PTGS2—hindlimb—leprosy	0.00144	0.0205	CbGeAlD
Ibuprofen—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.0014	0.0105	CcSEcCtD
Ibuprofen—THBD—tendon—leprosy	0.0014	0.0199	CbGeAlD
Ibuprofen—Nuchal rigidity—Thalidomide—leprosy	0.00138	0.0104	CcSEcCtD
Ibuprofen—PPARG—blood vessel—leprosy	0.00134	0.0191	CbGeAlD
Ibuprofen—BCL2—skin of body—leprosy	0.00129	0.0184	CbGeAlD
Ibuprofen—Vesiculobullous rash—Thalidomide—leprosy	0.00128	0.00959	CcSEcCtD
Ibuprofen—Foetor hepaticus—Thalidomide—leprosy	0.00126	0.00947	CcSEcCtD
Ibuprofen—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00123	0.00925	CcSEcCtD
Ibuprofen—Gastric ulcer—Thalidomide—leprosy	0.00123	0.00925	CcSEcCtD
Ibuprofen—PTGS2—appendage—leprosy	0.00123	0.0176	CbGeAlD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.00118	0.0322	CbGpPWpGaD
Ibuprofen—THBD—testis—leprosy	0.00116	0.0165	CbGeAlD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—TNFSF15—leprosy	0.00114	0.031	CbGpPWpGaD
Ibuprofen—THBD—nervous system—leprosy	0.00113	0.0162	CbGeAlD
Ibuprofen—PLAT—Beta2 integrin cell surface interactions—CD40LG—leprosy	0.00113	0.0308	CbGpPWpGaD
Ibuprofen—Liver disorder—Thalidomide—leprosy	0.00105	0.00789	CcSEcCtD
Ibuprofen—Neuralgia—Thalidomide—leprosy	0.00103	0.00774	CcSEcCtD
Ibuprofen—PTGS2—skin epidermis—leprosy	0.00102	0.0146	CbGeAlD
Ibuprofen—Metrorrhagia—Thalidomide—leprosy	0.001	0.00753	CcSEcCtD
Ibuprofen—PLAT—tendon—leprosy	0.000984	0.014	CbGeAlD
Ibuprofen—Neuritis—Thalidomide—leprosy	0.000961	0.0072	CcSEcCtD
Ibuprofen—Cholestasis—Thalidomide—leprosy	0.000944	0.00708	CcSEcCtD
Ibuprofen—Amblyopia—Thalidomide—leprosy	0.000929	0.00696	CcSEcCtD
Ibuprofen—Rash pustular—Thalidomide—leprosy	0.000899	0.00674	CcSEcCtD
Ibuprofen—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—leprosy	0.000891	0.0242	CbGpPWpGaD
Ibuprofen—Influenza—Dapsone—leprosy	0.000879	0.00659	CcSEcCtD
Ibuprofen—Pancreatitis—Dapsone—leprosy	0.000862	0.00646	CcSEcCtD
Ibuprofen—Blood disorder—Thalidomide—leprosy	0.000859	0.00644	CcSEcCtD
Ibuprofen—Apnoea—Thalidomide—leprosy	0.000846	0.00634	CcSEcCtD
Ibuprofen—BCL2—Apoptosis—LTA—leprosy	0.000835	0.0227	CbGpPWpGaD
Ibuprofen—CFTR—testis—leprosy	0.000825	0.0118	CbGeAlD
Ibuprofen—Proteinuria—Thalidomide—leprosy	0.000816	0.00612	CcSEcCtD
Ibuprofen—Vasodilation procedure—Thalidomide—leprosy	0.000816	0.00612	CcSEcCtD
Ibuprofen—Vasodilation—Thalidomide—leprosy	0.000816	0.00612	CcSEcCtD
Ibuprofen—PLAT—testis—leprosy	0.000815	0.0116	CbGeAlD
Ibuprofen—BCL2—testis—leprosy	0.000815	0.0116	CbGeAlD
Ibuprofen—Protein urine present—Thalidomide—leprosy	0.000805	0.00603	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Dapsone—leprosy	0.000802	0.00601	CcSEcCtD
Ibuprofen—BCL2—nervous system—leprosy	0.0008	0.0114	CbGeAlD
Ibuprofen—Musculoskeletal stiffness—Thalidomide—leprosy	0.000799	0.00599	CcSEcCtD
Ibuprofen—Hypocalcaemia—Thalidomide—leprosy	0.000783	0.00587	CcSEcCtD
Ibuprofen—Oliguria—Thalidomide—leprosy	0.000778	0.00583	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Dapsone—leprosy	0.000768	0.00576	CcSEcCtD
Ibuprofen—CXCL8—testis—leprosy	0.000754	0.0108	CbGeAlD
Ibuprofen—Hearing impaired—Thalidomide—leprosy	0.000753	0.00565	CcSEcCtD
Ibuprofen—Creatinine increased—Thalidomide—leprosy	0.000753	0.00565	CcSEcCtD
Ibuprofen—Sinusitis—Dapsone—leprosy	0.000735	0.00551	CcSEcCtD
Ibuprofen—Hepatocellular injury—Thalidomide—leprosy	0.000717	0.00538	CcSEcCtD
Ibuprofen—PTGS1—blood vessel—leprosy	0.000717	0.0102	CbGeAlD
Ibuprofen—Eructation—Thalidomide—leprosy	0.000705	0.00528	CcSEcCtD
Ibuprofen—Pharyngitis—Dapsone—leprosy	0.000698	0.00523	CcSEcCtD
Ibuprofen—Colitis—Thalidomide—leprosy	0.000689	0.00516	CcSEcCtD
Ibuprofen—PTGS2—blood vessel—leprosy	0.000685	0.00977	CbGeAlD
Ibuprofen—Blood urea increased—Thalidomide—leprosy	0.000677	0.00508	CcSEcCtD
Ibuprofen—Aplastic anaemia—Thalidomide—leprosy	0.000673	0.00505	CcSEcCtD
Ibuprofen—Dry eye—Thalidomide—leprosy	0.000662	0.00497	CcSEcCtD
Ibuprofen—BCL2—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	0.00066	0.018	CbGpPWpGaD
Ibuprofen—Tinnitus—Dapsone—leprosy	0.000656	0.00492	CcSEcCtD
Ibuprofen—Oesophagitis—Thalidomide—leprosy	0.000655	0.00491	CcSEcCtD
Ibuprofen—BCL2—Validated targets of C-MYC transcriptional repression—SLC11A1—leprosy	0.000654	0.0178	CbGpPWpGaD
Ibuprofen—SLC22A8—eye—leprosy	0.000643	0.00917	CbGeAlD
Ibuprofen—Lightheadedness—Thalidomide—leprosy	0.000642	0.00481	CcSEcCtD
Ibuprofen—Gynaecomastia—Thalidomide—leprosy	0.000642	0.00481	CcSEcCtD
Ibuprofen—UGT2B7—testis—leprosy	0.000641	0.00914	CbGeAlD
Ibuprofen—Hypertonia—Thalidomide—leprosy	0.000629	0.00471	CcSEcCtD
Ibuprofen—Hyperkinesia—Thalidomide—leprosy	0.000625	0.00469	CcSEcCtD
Ibuprofen—Sepsis—Thalidomide—leprosy	0.000622	0.00467	CcSEcCtD
Ibuprofen—PPARG—skin of body—leprosy	0.000621	0.00885	CbGeAlD
Ibuprofen—Euphoric mood—Thalidomide—leprosy	0.000616	0.00462	CcSEcCtD
Ibuprofen—Erythema—Dapsone—leprosy	0.000612	0.00459	CcSEcCtD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TLR1—leprosy	0.000612	0.0167	CbGpPWpGaD
Ibuprofen—Lymphadenopathy—Thalidomide—leprosy	0.00061	0.00457	CcSEcCtD
Ibuprofen—Photosensitivity—Thalidomide—leprosy	0.000593	0.00444	CcSEcCtD
Ibuprofen—Gastroenteritis—Thalidomide—leprosy	0.000587	0.0044	CcSEcCtD
Ibuprofen—Vascular purpura—Thalidomide—leprosy	0.000582	0.00436	CcSEcCtD
Ibuprofen—Deafness—Thalidomide—leprosy	0.000582	0.00436	CcSEcCtD
Ibuprofen—Vision blurred—Dapsone—leprosy	0.000577	0.00433	CcSEcCtD
Ibuprofen—Cardiac failure congestive—Thalidomide—leprosy	0.000574	0.0043	CcSEcCtD
Ibuprofen—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RIPK2—leprosy	0.000574	0.0156	CbGpPWpGaD
Ibuprofen—Renal failure acute—Thalidomide—leprosy	0.000564	0.00423	CcSEcCtD
Ibuprofen—Libido decreased—Thalidomide—leprosy	0.000561	0.00421	CcSEcCtD
Ibuprofen—Dermatitis exfoliative—Thalidomide—leprosy	0.000552	0.00414	CcSEcCtD
Ibuprofen—Vertigo—Dapsone—leprosy	0.00055	0.00412	CcSEcCtD
Ibuprofen—Visual disturbance—Thalidomide—leprosy	0.000549	0.00412	CcSEcCtD
Ibuprofen—Dermatitis bullous—Thalidomide—leprosy	0.000545	0.00408	CcSEcCtD
Ibuprofen—Purpura—Thalidomide—leprosy	0.00054	0.00405	CcSEcCtD
Ibuprofen—Arthritis—Thalidomide—leprosy	0.000536	0.00402	CcSEcCtD
Ibuprofen—Cough—Dapsone—leprosy	0.000534	0.00401	CcSEcCtD
Ibuprofen—Hypoglycaemia—Thalidomide—leprosy	0.000533	0.004	CcSEcCtD
Ibuprofen—Cardiac failure—Thalidomide—leprosy	0.000533	0.004	CcSEcCtD
Ibuprofen—Cerebrovascular accident—Thalidomide—leprosy	0.000531	0.00398	CcSEcCtD
Ibuprofen—Hyponatraemia—Thalidomide—leprosy	0.000523	0.00392	CcSEcCtD
Ibuprofen—Diplopia—Thalidomide—leprosy	0.000521	0.0039	CcSEcCtD
Ibuprofen—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000521	0.0039	CcSEcCtD
Ibuprofen—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—leprosy	0.00052	0.0142	CbGpPWpGaD
Ibuprofen—Disturbance in sexual arousal—Thalidomide—leprosy	0.000516	0.00387	CcSEcCtD
Ibuprofen—Affect lability—Thalidomide—leprosy	0.000512	0.00384	CcSEcCtD
Ibuprofen—Mood swings—Thalidomide—leprosy	0.000493	0.0037	CcSEcCtD
Ibuprofen—Tachycardia—Dapsone—leprosy	0.000488	0.00366	CcSEcCtD
Ibuprofen—Blood creatinine increased—Thalidomide—leprosy	0.000488	0.00366	CcSEcCtD
Ibuprofen—SLCO2B1—tendon—leprosy	0.000485	0.00691	CbGeAlD
Ibuprofen—Liver function test abnormal—Thalidomide—leprosy	0.000481	0.0036	CcSEcCtD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	0.000478	0.013	CbGpPWpGaD
Ibuprofen—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000477	0.013	CbGpPWpGaD
Ibuprofen—Hypokalaemia—Thalidomide—leprosy	0.000474	0.00355	CcSEcCtD
Ibuprofen—PPARG—tendon—leprosy	0.000473	0.00674	CbGeAlD
Ibuprofen—Cramp muscle—Thalidomide—leprosy	0.000469	0.00351	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000469	0.00351	CcSEcCtD
Ibuprofen—Abdominal distension—Thalidomide—leprosy	0.000453	0.0034	CcSEcCtD
Ibuprofen—Insomnia—Dapsone—leprosy	0.000452	0.00339	CcSEcCtD
Ibuprofen—Influenza—Thalidomide—leprosy	0.00045	0.00337	CcSEcCtD
Ibuprofen—Dysphagia—Thalidomide—leprosy	0.00045	0.00337	CcSEcCtD
Ibuprofen—Eosinophilia—Thalidomide—leprosy	0.000445	0.00334	CcSEcCtD
Ibuprofen—Bronchospasm—Thalidomide—leprosy	0.000443	0.00332	CcSEcCtD
Ibuprofen—Pancreatitis—Thalidomide—leprosy	0.000441	0.00331	CcSEcCtD
Ibuprofen—Bronchitis—Thalidomide—leprosy	0.000433	0.00324	CcSEcCtD
Ibuprofen—ABCC4—tendon—leprosy	0.000429	0.00612	CbGeAlD
Ibuprofen—Pancytopenia—Thalidomide—leprosy	0.000427	0.0032	CcSEcCtD
Ibuprofen—PLAT—Vitamin B12 Metabolism—IFNG—leprosy	0.000424	0.0115	CbGpPWpGaD
Ibuprofen—ABCB1—blood vessel—leprosy	0.000424	0.00604	CbGeAlD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000423	0.0115	CbGpPWpGaD
Ibuprofen—Neutropenia—Thalidomide—leprosy	0.000421	0.00315	CcSEcCtD
Ibuprofen—Pollakiuria—Thalidomide—leprosy	0.000416	0.00312	CcSEcCtD
Ibuprofen—Erectile dysfunction—Thalidomide—leprosy	0.000414	0.00311	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Thalidomide—leprosy	0.000411	0.00308	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Dapsone—leprosy	0.000409	0.00306	CcSEcCtD
Ibuprofen—Weight decreased—Thalidomide—leprosy	0.000407	0.00305	CcSEcCtD
Ibuprofen—Hyperglycaemia—Thalidomide—leprosy	0.000406	0.00304	CcSEcCtD
Ibuprofen—Pneumonia—Thalidomide—leprosy	0.000404	0.00302	CcSEcCtD
Ibuprofen—SLCO2B1—testis—leprosy	0.000401	0.00572	CbGeAlD
Ibuprofen—Drowsiness—Thalidomide—leprosy	0.000401	0.00301	CcSEcCtD
Ibuprofen—Depression—Thalidomide—leprosy	0.0004	0.003	CcSEcCtD
Ibuprofen—PLAT—amb2 Integrin signaling—TNF—leprosy	0.000399	0.0108	CbGpPWpGaD
Ibuprofen—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000398	0.00298	CcSEcCtD
Ibuprofen—Acute coronary syndrome—Thalidomide—leprosy	0.000395	0.00296	CcSEcCtD
Ibuprofen—Abdominal pain—Dapsone—leprosy	0.000395	0.00296	CcSEcCtD
Ibuprofen—Renal failure—Thalidomide—leprosy	0.000394	0.00296	CcSEcCtD
Ibuprofen—SLCO2B1—nervous system—leprosy	0.000394	0.00561	CbGeAlD
Ibuprofen—Myocardial infarction—Thalidomide—leprosy	0.000393	0.00295	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Thalidomide—leprosy	0.000393	0.00295	CcSEcCtD
Ibuprofen—PPARG—testis—leprosy	0.000391	0.00558	CbGeAlD
Ibuprofen—Stomatitis—Thalidomide—leprosy	0.000391	0.00293	CcSEcCtD
Ibuprofen—Conjunctivitis—Thalidomide—leprosy	0.00039	0.00292	CcSEcCtD
Ibuprofen—Sweating—Thalidomide—leprosy	0.000385	0.00288	CcSEcCtD
Ibuprofen—PPARG—nervous system—leprosy	0.000384	0.00548	CbGeAlD
Ibuprofen—Haematuria—Thalidomide—leprosy	0.000383	0.00287	CcSEcCtD
Ibuprofen—Epistaxis—Thalidomide—leprosy	0.000378	0.00284	CcSEcCtD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	0.000378	0.0103	CbGpPWpGaD
Ibuprofen—Sinusitis—Thalidomide—leprosy	0.000376	0.00282	CcSEcCtD
Ibuprofen—Agranulocytosis—Thalidomide—leprosy	0.000374	0.00281	CcSEcCtD
Ibuprofen—SLCO1A2—testis—leprosy	0.000369	0.00526	CbGeAlD
Ibuprofen—ALB—testis—leprosy	0.000367	0.00523	CbGeAlD
Ibuprofen—ABCC1—tendon—leprosy	0.000366	0.00522	CbGeAlD
Ibuprofen—CFTR—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000365	0.00993	CbGpPWpGaD
Ibuprofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000364	0.0099	CbGpPWpGaD
Ibuprofen—BCL2—Overview of nanoparticle effects—TNF—leprosy	0.000363	0.00988	CbGpPWpGaD
Ibuprofen—SLCO1A2—nervous system—leprosy	0.000363	0.00517	CbGeAlD
Ibuprofen—Rhinitis—Thalidomide—leprosy	0.000361	0.00271	CcSEcCtD
Ibuprofen—Hepatitis—Thalidomide—leprosy	0.00036	0.0027	CcSEcCtD
Ibuprofen—Pharyngitis—Thalidomide—leprosy	0.000357	0.00268	CcSEcCtD
Ibuprofen—Urinary tract disorder—Thalidomide—leprosy	0.000356	0.00267	CcSEcCtD
Ibuprofen—ABCC4—testis—leprosy	0.000355	0.00507	CbGeAlD
Ibuprofen—Oedema peripheral—Thalidomide—leprosy	0.000355	0.00266	CcSEcCtD
Ibuprofen—Urethral disorder—Thalidomide—leprosy	0.000353	0.00265	CcSEcCtD
Ibuprofen—CXCL8—Overview of nanoparticle effects—TNF—leprosy	0.000349	0.00949	CbGpPWpGaD
Ibuprofen—ABCC4—nervous system—leprosy	0.000349	0.00497	CbGeAlD
Ibuprofen—Visual impairment—Thalidomide—leprosy	0.000347	0.0026	CcSEcCtD
Ibuprofen—SLC22A8—nervous system—leprosy	0.000346	0.00493	CbGeAlD
Ibuprofen—BCL2—IL2 signaling events mediated by STAT5—IL2—leprosy	0.000346	0.00941	CbGpPWpGaD
Ibuprofen—PLAT—Folate Metabolism—IFNG—leprosy	0.000345	0.00939	CbGpPWpGaD
Ibuprofen—Erythema multiforme—Thalidomide—leprosy	0.000341	0.00255	CcSEcCtD
Ibuprofen—Tinnitus—Thalidomide—leprosy	0.000336	0.00252	CcSEcCtD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000333	0.00906	CbGpPWpGaD
Ibuprofen—PTGS1—skin of body—leprosy	0.000332	0.00473	CbGeAlD
Ibuprofen—Immune system disorder—Thalidomide—leprosy	0.000325	0.00244	CcSEcCtD
Ibuprofen—Mediastinal disorder—Thalidomide—leprosy	0.000325	0.00243	CcSEcCtD
Ibuprofen—Chills—Thalidomide—leprosy	0.000323	0.00242	CcSEcCtD
Ibuprofen—CXCL8—AP-1 transcription factor network—IL10—leprosy	0.000323	0.00879	CbGpPWpGaD
Ibuprofen—Arrhythmia—Thalidomide—leprosy	0.000322	0.00241	CcSEcCtD
Ibuprofen—Alopecia—Thalidomide—leprosy	0.000318	0.00239	CcSEcCtD
Ibuprofen—Vomiting—Dapsone—leprosy	0.000318	0.00238	CcSEcCtD
Ibuprofen—PTGS2—skin of body—leprosy	0.000317	0.00452	CbGeAlD
Ibuprofen—Mental disorder—Thalidomide—leprosy	0.000316	0.00237	CcSEcCtD
Ibuprofen—Malnutrition—Thalidomide—leprosy	0.000314	0.00235	CcSEcCtD
Ibuprofen—Headache—Dapsone—leprosy	0.000313	0.00235	CcSEcCtD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TLR2—leprosy	0.000312	0.00849	CbGpPWpGaD
Ibuprofen—Flatulence—Thalidomide—leprosy	0.000309	0.00232	CcSEcCtD
Ibuprofen—Tension—Thalidomide—leprosy	0.000308	0.00231	CcSEcCtD
Ibuprofen—Dysgeusia—Thalidomide—leprosy	0.000307	0.0023	CcSEcCtD
Ibuprofen—PLAT—Folate Metabolism—IL2—leprosy	0.000307	0.00835	CbGpPWpGaD
Ibuprofen—Nervousness—Thalidomide—leprosy	0.000305	0.00228	CcSEcCtD
Ibuprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000304	0.00826	CbGpPWpGaD
Ibuprofen—ABCC1—testis—leprosy	0.000303	0.00432	CbGeAlD
Ibuprofen—Muscle spasms—Thalidomide—leprosy	0.000301	0.00226	CcSEcCtD
Ibuprofen—CXCL8—EBV LMP1 signaling—TNF—leprosy	0.000299	0.00815	CbGpPWpGaD
Ibuprofen—Nausea—Dapsone—leprosy	0.000297	0.00223	CcSEcCtD
Ibuprofen—Vision blurred—Thalidomide—leprosy	0.000295	0.00221	CcSEcCtD
Ibuprofen—Tremor—Thalidomide—leprosy	0.000294	0.0022	CcSEcCtD
Ibuprofen—CXCL8—Allograft Rejection—IL10—leprosy	0.000293	0.00798	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—CD40LG—leprosy	0.000293	0.00798	CbGpPWpGaD
Ibuprofen—BCL2—IL2 signaling events mediated by PI3K—IL2—leprosy	0.000292	0.00796	CbGpPWpGaD
Ibuprofen—Ill-defined disorder—Thalidomide—leprosy	0.000291	0.00218	CcSEcCtD
Ibuprofen—Anaemia—Thalidomide—leprosy	0.00029	0.00217	CcSEcCtD
Ibuprofen—Agitation—Thalidomide—leprosy	0.000288	0.00216	CcSEcCtD
Ibuprofen—Angioedema—Thalidomide—leprosy	0.000286	0.00215	CcSEcCtD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—leprosy	0.000286	0.00779	CbGpPWpGaD
Ibuprofen—Malaise—Thalidomide—leprosy	0.000283	0.00212	CcSEcCtD
Ibuprofen—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—leprosy	0.000283	0.00769	CbGpPWpGaD
Ibuprofen—Vertigo—Thalidomide—leprosy	0.000282	0.00211	CcSEcCtD
Ibuprofen—Syncope—Thalidomide—leprosy	0.000281	0.00211	CcSEcCtD
Ibuprofen—Leukopenia—Thalidomide—leprosy	0.000281	0.0021	CcSEcCtD
Ibuprofen—Palpitations—Thalidomide—leprosy	0.000277	0.00208	CcSEcCtD
Ibuprofen—Loss of consciousness—Thalidomide—leprosy	0.000276	0.00207	CcSEcCtD
Ibuprofen—BCL2—IL-5 Signaling Pathway—IL2—leprosy	0.000275	0.00748	CbGpPWpGaD
Ibuprofen—PLAT—Vitamin B12 Metabolism—TNF—leprosy	0.000275	0.00747	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—IFNG—leprosy	0.000274	0.00746	CbGpPWpGaD
Ibuprofen—Cough—Thalidomide—leprosy	0.000274	0.00205	CcSEcCtD
Ibuprofen—Convulsion—Thalidomide—leprosy	0.000272	0.00204	CcSEcCtD
Ibuprofen—Hypertension—Thalidomide—leprosy	0.000271	0.00203	CcSEcCtD
Ibuprofen—Arthralgia—Thalidomide—leprosy	0.000267	0.002	CcSEcCtD
Ibuprofen—Myalgia—Thalidomide—leprosy	0.000267	0.002	CcSEcCtD
Ibuprofen—Anxiety—Thalidomide—leprosy	0.000266	0.00199	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000265	0.00199	CcSEcCtD
Ibuprofen—BCL2—IL-2 Signaling Pathway—IL2—leprosy	0.000264	0.00719	CbGpPWpGaD
Ibuprofen—Discomfort—Thalidomide—leprosy	0.000264	0.00198	CcSEcCtD
Ibuprofen—Dry mouth—Thalidomide—leprosy	0.000261	0.00196	CcSEcCtD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.00026	0.00708	CbGpPWpGaD
Ibuprofen—CYP2C8—testis—leprosy	0.000258	0.00368	CbGeAlD
Ibuprofen—Confusional state—Thalidomide—leprosy	0.000258	0.00193	CcSEcCtD
Ibuprofen—Oedema—Thalidomide—leprosy	0.000256	0.00192	CcSEcCtD
Ibuprofen—Infection—Thalidomide—leprosy	0.000254	0.00191	CcSEcCtD
Ibuprofen—PTGS1—tendon—leprosy	0.000253	0.0036	CbGeAlD
Ibuprofen—Shock—Thalidomide—leprosy	0.000252	0.00189	CcSEcCtD
Ibuprofen—Nervous system disorder—Thalidomide—leprosy	0.000251	0.00188	CcSEcCtD
Ibuprofen—Thrombocytopenia—Thalidomide—leprosy	0.000251	0.00188	CcSEcCtD
Ibuprofen—Tachycardia—Thalidomide—leprosy	0.00025	0.00187	CcSEcCtD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000249	0.00676	CbGpPWpGaD
Ibuprofen—Skin disorder—Thalidomide—leprosy	0.000249	0.00186	CcSEcCtD
Ibuprofen—Hyperhidrosis—Thalidomide—leprosy	0.000247	0.00185	CcSEcCtD
Ibuprofen—PPARG—Transcription factor regulation in adipogenesis—TNF—leprosy	0.000244	0.00665	CbGpPWpGaD
Ibuprofen—Anorexia—Thalidomide—leprosy	0.000244	0.00183	CcSEcCtD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	0.000243	0.00662	CbGpPWpGaD
Ibuprofen—BCL2—IL2-mediated signaling events—IFNG—leprosy	0.000243	0.00662	CbGpPWpGaD
Ibuprofen—PTGS2—tendon—leprosy	0.000242	0.00344	CbGeAlD
Ibuprofen—SLCO2B1—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000239	0.00651	CbGpPWpGaD
Ibuprofen—Hypotension—Thalidomide—leprosy	0.000239	0.00179	CcSEcCtD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000238	0.00648	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-DRB1—leprosy	0.000236	0.00642	CbGpPWpGaD
Ibuprofen—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—leprosy	0.000233	0.00635	CbGpPWpGaD
Ibuprofen—Musculoskeletal discomfort—Thalidomide—leprosy	0.000233	0.00175	CcSEcCtD
Ibuprofen—Insomnia—Thalidomide—leprosy	0.000231	0.00173	CcSEcCtD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.000231	0.0063	CbGpPWpGaD
Ibuprofen—Paraesthesia—Thalidomide—leprosy	0.00023	0.00172	CcSEcCtD
Ibuprofen—Dyspnoea—Thalidomide—leprosy	0.000228	0.00171	CcSEcCtD
Ibuprofen—Somnolence—Thalidomide—leprosy	0.000227	0.00171	CcSEcCtD
Ibuprofen—BCL2—ATF-2 transcription factor network—IFNG—leprosy	0.000227	0.00617	CbGpPWpGaD
Ibuprofen—Dyspepsia—Thalidomide—leprosy	0.000225	0.00169	CcSEcCtD
Ibuprofen—PLAT—Folate Metabolism—TNF—leprosy	0.000223	0.00608	CbGpPWpGaD
Ibuprofen—Decreased appetite—Thalidomide—leprosy	0.000222	0.00167	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Thalidomide—leprosy	0.000221	0.00166	CcSEcCtD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000221	0.00601	CbGpPWpGaD
Ibuprofen—Fatigue—Thalidomide—leprosy	0.000221	0.00165	CcSEcCtD
Ibuprofen—Constipation—Thalidomide—leprosy	0.000219	0.00164	CcSEcCtD
Ibuprofen—CXCL8—ATF-2 transcription factor network—IFNG—leprosy	0.000218	0.00593	CbGpPWpGaD
Ibuprofen—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000217	0.0059	CbGpPWpGaD
Ibuprofen—BCL2—IL2-mediated signaling events—IL2—leprosy	0.000216	0.00588	CbGpPWpGaD
Ibuprofen—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—leprosy	0.000214	0.00582	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Thalidomide—leprosy	0.000211	0.00158	CcSEcCtD
Ibuprofen—PTGS1—testis—leprosy	0.000209	0.00298	CbGeAlD
Ibuprofen—Gastrointestinal pain—Thalidomide—leprosy	0.000209	0.00157	CcSEcCtD
Ibuprofen—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—leprosy	0.000209	0.00567	CbGpPWpGaD
Ibuprofen—PTGS1—nervous system—leprosy	0.000205	0.00293	CbGeAlD
Ibuprofen—Urticaria—Thalidomide—leprosy	0.000203	0.00152	CcSEcCtD
Ibuprofen—Abdominal pain—Thalidomide—leprosy	0.000202	0.00152	CcSEcCtD
Ibuprofen—PTGS2—nervous system—leprosy	0.000196	0.0028	CbGeAlD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000196	0.00533	CbGpPWpGaD
Ibuprofen—PTGS1—Overview of nanoparticle effects—TNF—leprosy	0.000193	0.00524	CbGpPWpGaD
Ibuprofen—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—leprosy	0.000192	0.00524	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—IFNG—leprosy	0.00019	0.00517	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Thalidomide—leprosy	0.000189	0.00141	CcSEcCtD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	0.000185	0.00504	CbGpPWpGaD
Ibuprofen—Asthenia—Thalidomide—leprosy	0.000184	0.00138	CcSEcCtD
Ibuprofen—Pruritus—Thalidomide—leprosy	0.000181	0.00136	CcSEcCtD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.00018	0.00489	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	0.00018	0.00489	CbGpPWpGaD
Ibuprofen—PLAT—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000178	0.00485	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—TNF—leprosy	0.000177	0.00483	CbGpPWpGaD
Ibuprofen—Diarrhoea—Thalidomide—leprosy	0.000175	0.00131	CcSEcCtD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	0.000174	0.00474	CbGpPWpGaD
Ibuprofen—BCL2—Ceramide signaling pathway—TNF—leprosy	0.000173	0.00471	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IFNG—leprosy	0.000172	0.00469	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL10—leprosy	0.00017	0.00463	CbGpPWpGaD
Ibuprofen—Dizziness—Thalidomide—leprosy	0.000169	0.00127	CcSEcCtD
Ibuprofen—CXCL8—AP-1 transcription factor network—IL2—leprosy	0.000169	0.00459	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	0.000168	0.00459	CbGpPWpGaD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—leprosy	0.000168	0.00458	CbGpPWpGaD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—IFNG—leprosy	0.000167	0.00455	CbGpPWpGaD
Ibuprofen—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000165	0.0045	CbGpPWpGaD
Ibuprofen—BCL2—C-MYB transcription factor network—CD4—leprosy	0.000165	0.00449	CbGpPWpGaD
Ibuprofen—Vomiting—Thalidomide—leprosy	0.000163	0.00122	CcSEcCtD
Ibuprofen—Rash—Thalidomide—leprosy	0.000161	0.00121	CcSEcCtD
Ibuprofen—Dermatitis—Thalidomide—leprosy	0.000161	0.00121	CcSEcCtD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	0.000161	0.00438	CbGpPWpGaD
Ibuprofen—Headache—Thalidomide—leprosy	0.00016	0.0012	CcSEcCtD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.00016	0.00435	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	0.00016	0.00435	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL2—leprosy	0.000153	0.00417	CbGpPWpGaD
Ibuprofen—PTGS2—Overview of nanoparticle effects—TNF—leprosy	0.000153	0.00416	CbGpPWpGaD
Ibuprofen—Nausea—Thalidomide—leprosy	0.000152	0.00114	CcSEcCtD
Ibuprofen—BCL2—Caspase Cascade in Apoptosis—TNF—leprosy	0.000151	0.0041	CbGpPWpGaD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—leprosy	0.00015	0.00407	CbGpPWpGaD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—IL2—leprosy	0.000149	0.00405	CbGpPWpGaD
Ibuprofen—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000147	0.00399	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000143	0.00389	CbGpPWpGaD
Ibuprofen—BCL2—Corticotropin-releasing hormone—IL2—leprosy	0.000141	0.00384	CbGpPWpGaD
Ibuprofen—THBD—Hemostasis—IL2—leprosy	0.000138	0.00376	CbGpPWpGaD
Ibuprofen—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—leprosy	0.000138	0.00375	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IFNG—leprosy	0.000137	0.00374	CbGpPWpGaD
Ibuprofen—CXCL8—Corticotropin-releasing hormone—IL2—leprosy	0.000136	0.00369	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	0.000127	0.00345	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CYLD—leprosy	0.000126	0.00343	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IFNG—leprosy	0.000125	0.0034	CbGpPWpGaD
Ibuprofen—ABCB1—testis—leprosy	0.000124	0.00176	CbGeAlD
Ibuprofen—SLCO2B1—Transmembrane transport of small molecules—SLC11A1—leprosy	0.000122	0.00331	CbGpPWpGaD
Ibuprofen—ABCB1—nervous system—leprosy	0.000121	0.00173	CbGeAlD
Ibuprofen—UGT2B4—Metabolism—SDHD—leprosy	0.000117	0.00319	CbGpPWpGaD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	0.000116	0.00317	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	0.000116	0.00317	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—TNF—leprosy	0.000112	0.00304	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IL2—leprosy	0.000111	0.00302	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TNF—leprosy	0.000111	0.00301	CbGpPWpGaD
Ibuprofen—SLC22A11—Transmembrane transport of small molecules—SLC11A1—leprosy	0.00011	0.003	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	0.000109	0.00296	CbGpPWpGaD
Ibuprofen—PPARG—Signaling events mediated by HDAC Class I—TNF—leprosy	9.68e-05	0.00264	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	9.68e-05	0.00263	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL10—leprosy	9.1e-05	0.00248	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CD40LG—leprosy	9.1e-05	0.00248	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—leprosy	9.1e-05	0.00248	CbGpPWpGaD
Ibuprofen—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—leprosy	8.97e-05	0.00244	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—IFNG—leprosy	8.73e-05	0.00237	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—IFNG—leprosy	8.67e-05	0.00236	CbGpPWpGaD
Ibuprofen—SLC22A8—Transmembrane transport of small molecules—SLC11A1—leprosy	8.4e-05	0.00229	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—TLR2—leprosy	8.11e-05	0.00221	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—RIPK2—leprosy	8.11e-05	0.00221	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—TNF—leprosy	8.09e-05	0.0022	CbGpPWpGaD
Ibuprofen—ABCC4—Transmembrane transport of small molecules—SLC11A1—leprosy	8.05e-05	0.00219	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—leprosy	7.53e-05	0.00205	CbGpPWpGaD
Ibuprofen—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—leprosy	7.46e-05	0.00203	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—NOD2—leprosy	7.35e-05	0.002	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CYLD—leprosy	7.33e-05	0.002	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	7.33e-05	0.00199	CbGpPWpGaD
Ibuprofen—ALB—SLC-mediated transmembrane transport—SLC11A1—leprosy	7.17e-05	0.00195	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—leprosy	7.1e-05	0.00193	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IFNG—leprosy	7.06e-05	0.00192	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—leprosy	7.05e-05	0.00192	CbGpPWpGaD
Ibuprofen—SLC22A6—Transmembrane transport of small molecules—SLC11A1—leprosy	7.01e-05	0.00191	CbGpPWpGaD
Ibuprofen—PTGS2—C-MYB transcription factor network—CD4—leprosy	6.94e-05	0.00189	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—IFNG—leprosy	6.93e-05	0.00189	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TNF—leprosy	6.77e-05	0.00184	CbGpPWpGaD
Ibuprofen—ABCC1—Transmembrane transport of small molecules—SLC11A1—leprosy	6.71e-05	0.00183	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—PARK2—leprosy	6.48e-05	0.00176	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—TNF—leprosy	6.47e-05	0.00176	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—SDHD—leprosy	6.28e-05	0.00171	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—IL2—leprosy	6.27e-05	0.00171	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—IL2—leprosy	6.01e-05	0.00164	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—TNF—leprosy	5.9e-05	0.00161	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	5.73e-05	0.00156	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—TNF—leprosy	5.65e-05	0.00154	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—TNF—leprosy	5.61e-05	0.00153	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—IFNG—leprosy	5.6e-05	0.00153	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IFNG—leprosy	5.48e-05	0.00149	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IFNG—leprosy	5.35e-05	0.00146	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—SDHD—leprosy	5.34e-05	0.00145	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—IL2—leprosy	5.27e-05	0.00143	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—RIPK2—leprosy	5.09e-05	0.00139	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—SDHD—leprosy	5.05e-05	0.00137	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—IL2—leprosy	4.87e-05	0.00132	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—IL2—leprosy	4.76e-05	0.00129	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—RIPK2—leprosy	4.72e-05	0.00129	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—TLR2—leprosy	4.72e-05	0.00129	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—SDHD—leprosy	4.65e-05	0.00126	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—TNF—leprosy	4.57e-05	0.00124	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—TNF—leprosy	4.48e-05	0.00122	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—SDHD—leprosy	4.34e-05	0.00118	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—SDHD—leprosy	4.34e-05	0.00118	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—NOD2—leprosy	4.28e-05	0.00117	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—SDHD—leprosy	4.18e-05	0.00114	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—SLC11A1—leprosy	3.75e-05	0.00102	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—SLC11A1—leprosy	3.64e-05	0.000992	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—TNF—leprosy	3.63e-05	0.000987	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD40LG—leprosy	3.62e-05	0.000985	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD8A—leprosy	3.58e-05	0.000974	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TNF—leprosy	3.55e-05	0.000965	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—SDHD—leprosy	3.54e-05	0.000962	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CD4—leprosy	3.53e-05	0.000961	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—TNF—leprosy	3.47e-05	0.000943	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	3.19e-05	0.000869	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—RIPK2—leprosy	2.94e-05	0.000799	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-DRB1—leprosy	2.92e-05	0.000793	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—SDHD—leprosy	2.81e-05	0.000764	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—IL2—leprosy	2.72e-05	0.000739	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SLC11A1—leprosy	2.52e-05	0.000686	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.41e-05	0.000656	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—IL2—leprosy	2.38e-05	0.000649	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—SDHD—leprosy	2.28e-05	0.000621	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—SDHD—leprosy	2.27e-05	0.000618	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—IL2—leprosy	2.19e-05	0.000596	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IFNG—leprosy	2.13e-05	0.000579	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD4—leprosy	2.06e-05	0.00056	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—SDHD—leprosy	2.04e-05	0.000555	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IL2—leprosy	2.04e-05	0.000555	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—TNF—leprosy	2.03e-05	0.000552	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—IL2—leprosy	1.99e-05	0.000542	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—SDHD—leprosy	1.99e-05	0.000541	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL2—leprosy	1.89e-05	0.000515	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—SDHD—leprosy	1.86e-05	0.000506	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.71e-05	0.000465	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IL2—leprosy	1.23e-05	0.000334	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CD4—leprosy	1.19e-05	0.000324	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL2—leprosy	1.18e-05	0.00032	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CD4—leprosy	7.99e-06	0.000218	CbGpPWpGaD
